Kolexia
Raccah Denis Endocrinologie
Raccah Denis
Endocrinologie
Cabinet libéral
Marseille, France
105 Activités
4 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Diabète Diabète de type 2 Hypoglycémie Diabète de type 1 Hyperglycémie Insulinorésistance Nausée Maladies métaboliques Obésité

Collaborateurs

Voir plus
Guerci Bruno
Guerci Bruno
Hôpital Brabois, Vandoeuvre-lès-Nancy, France
Gourdy Pierre
Gourdy Pierre
Hôpital Rangueil, Toulouse, France
Schaepelynck-Belicar Pauline
Schaepelynck-Belicar Pauline
Hôpital Sainte Marguerite, Marseille, France
Penfornis Alfred
Penfornis Alfred
Centre Hospitalier Sud Francilien, Corbeil-Essonnes, France

Industries

Voir plus
Sanofi
37 collaboration(s)
Dernière en 2023
AstraZeneca
14 collaboration(s)
Dernière en 2023
Lilly
2 collaboration(s)
Dernière en 2022
Novo Nordisk
2 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
Reply to Letter by Alexander Seibold on "Impact of Switching from Intermittently Scanned to Real-Time Continuous Glucose Monitoring Systems in a Type 1 Diabetes Patient French Cohort: An Observational Study of Clinical Practices" by Yannis Préau, et al. (doi: 10.1089/dia.2020.0674).
Diabetes technology & therapeutics   28 mars 2022
Benefits of a Switch from Intermittently Scanned Continuous Glucose Monitoring (isCGM) to Real-Time (rt) CGM in Diabetes Type 1 Suboptimal Controlled Patients in Real-Life: A One-Year Prospective Study .
Sensors (Basel, Switzerland)   13 septembre 2021
Impact of Switching from Intermittently Scanned to Real-Time Continuous Glucose Monitoring Systems in a Type 1 Diabetes Patient French Cohort: An Observational Study of Clinical Practices.
Diabetes technology & therapeutics   25 novembre 2020
Fixed-Ratio Combination of Insulin and GLP-1 RA in Patients with Longstanding Type 2 Diabetes: A Subanalysis of LixiLan-L.
Diabetes therapy : research, treatment and education of diabetes and related disorders   12 mars 2020
Efficacy and safety of lixisenatide in the treatment of Type 2 diabetes mellitus: a review of Phase III clinical data.
Expert review of endocrinology & metabolism   20 novembre 2019
Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial.
The Lancet. Digital health   02 mai 2019
Professeurs Denis Raccah & René Valero, organisateurs du ... - Facebook
Facebook   29 mars 2019
Clinical implications of prolonged hyperglycaemia before basal insulin initiation in type 2 diabetes patients: An electronic medical record database analysis.
Endocrinology, diabetes & metabolism   28 mars 2019
WP7: Crossover Evaluation of the Safety and the Efficacy of Artificial Pancreas Diabeloop for Three Months at Home in Comparison With Conventional Treatment by External Insulin Pump in Patients With Type 1 Diabetes.
Essai Clinique (Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète)   30 janvier 2019
RTD: To Assess Whether Type 1 Diabetic Patients Treated With M D I and in Poor Metabolic Control Can Improve Using the Paradigm® Real Time System Compared to Self-Monitoring Blood Glucose and Continuous Subcutaneous Insulin Infusion
Essai Clinique (Medtronic)   03 décembre 2018